Eddingpharm gains Chinese rights to Amarin's Vascepa

Amarin Corp. plc (NASDAQ:AMRN) granted Eddingpharm Inc. (Shanghai, China) exclusive rights to

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE